The Journal for Nurse Practitioners
Volume 3, Issue 2 , Pages 85-89 , February 2007

Matching Insulin to Patient: How to Make the Best Use of Premixed Insulin Analog Formulations

  • Virginia Peragallo-Dittko, APRN, BC-ADM, CDE

      Affiliations

    • Virginia Peragallo-Dittko, APRN, BC-ADM, CDE, has been the director of the Diabetes Education Center at Winthrop-University Hospital in Mineola, NY, since 1985. She holds academic appointments as clinical associate faculty for graduate education. She serves as editor-in-chief of program publications for the American Diabetes Association. In 1990, she was named Diabetes Educator of the Year by the American Association of Diabetes Educators and was named 2002 Diabetes Educator of the Year and 2004 Administrator of the Year by the Metropolitan New York Association of Diabetes Educators. She also serves on the Education Council for the National Diabetes Education Initiative. She serves on continuing education advisory boards for Novo-Nordisk Inc. and Eli Lilly and Company. Although this article is her own work, Novo-Nordisk provided editorial support of this manuscript.

References 

  1. Jacobsen LV , Søgaard B , Riis A . Pharmacokinetics and pharmacodynamics of a premixed formulation of soluble and protamine-retarded insulin aspart . Eur J Clin Pharmacol. . 2000;56(5):399–403
  2. Heise T , Weyer C , Serwas A , et al.   Time-action profiles of novel premixed preparations of insulin lispro and NPL insulin . Diabetes Care. . 1998;21(5):800–803
  3. UK Prospective Diabetes Study 7: response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients. UKPDS Group . Metabolism. . 1990;39(9):905–912
  4. Abrahamson MJ . Optimal glycemic control in type 2 diabetes mellitus: fasting and postprandial glucose in context . Arch Intern Med. . 2004;164(5):486–491
  5. Boehm BO , Home PD , Behrend C , et al.   Premixed insulin aspart 30 vs premixed human insulin 30/70 twice daily: a randomized trial in type 1 and type 2 diabetic patients . Diabetic Med. . 2002;19(5):393–399
  6. Herz M , Arora V , Campaigne BN , et al.   Humalog Mix 25 improves 24-hour plasma glucose profiles compared with the human insulin mixture 30/70 in patients with type 2 diabetes mellitus . S Afr Med J. . 2003;93(3):219–223
  7. DeWitt DE , Dugdale DC . Using new insulin strategies in the outpatient treatment of diabetes: clinical applications . JAMA . 2003;289(17):2265–2269
  8. Mudaliar S , Edelman SV . Insulin therapy in type 2 diabetes . Endocrinol Metab Clin North Am. . 2001;30(4):935–982

PII: S1555-4155(06)00678-7

doi: 10.1016/j.nurpra.2006.09.005

The Journal for Nurse Practitioners
Volume 3, Issue 2 , Pages 85-89 , February 2007

Article Tools